Vaxil Bio Ltd.

C$0.11As of Sun 8 Nov 2026, 12:00 UTC
TASE:PSRXHealthcare
Country Israel
PE (Fwd) •••
TSR 10Y CAGR (34.16%)
Div yield —
ROE —
Biotechnology
Beta (5Y) (0.19)
PE TTM —
TSR TTM (38.89%)
Mkt cap C$0.438M
ROIC —
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.141
28.57%
(54.26%)
Hold 10|10|12|5|10
4Q25
1Q26
2Q26
3Q26
Earnings per share$
—
—
—
—
18.43%
29.99%
25.56%
23.00%
Revenue$M
0.023
0.024
0.023
0.024
4.94%
2.60%
(2.79%)
0.42%
Peers (US$2.892M)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
1.026
0.799
0.709
EBIT/Intx
0.806
0.501
0.541
Own earn%
(31.96)
162.36
147.62
Sh yield%
32.76
15.02
14.05
Owners
Insiders/Inst%
13.47
73.66
Short interest%
2.44
SBC / revenue%
0.48
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
7
Op margin range%
8–20
$1 testx
—
Incr. ROIC%
1